EP3380194 - Bibliographic data

COMPOSITION DE BLOCAGE DE L'ANGIOGENÈSE

Last update 22/05/2025
Legal status Brevet déchu
Origin Euro-PCT

(73) Holder

Indiana University Research & Technology Corporation

518 Indiana Avenue
Indianapolis, IN 46202
États-Unis d'Amérique
(72) Inventors

Timothy William CORSON

c/o Indiana University Research and Technology Corporation 518 Indiana Avenue
Indianapolis, Indiana 46202
États-Unis d'Amérique

Rania SULAIMAN

c/o Indiana University Research and Technology Corporation 518 Indiana Avenue
Indianapolis, Indiana 46202
États-Unis d'Amérique
(74) Agent

Mail recipient

HGF

HGF Limited 1 City Walk
Leeds LS11 9DX
Royaume-Uni

(21) Request number EP16869113.7
(22) Request date 18/11/2016

(11) Publication number EP3380194
Publication date 01/11/2023

(54) Title of the invention COMPOSITION DE BLOCAGE DE L'ANGIOGENÈSE
(51) International classification A61K 31/335A61K 31/353A61K 31/343A61K 31/35A61P 27/02A61P 17/02A61P 9/10A61P 9/00A61P 3/04A61K 39/395
International classification (before reform) None

Claimed priority

(31) Number: 201562259281 P
(32) Date: 24/11/2015
(33) Country: US

Initial application None
Divisional application None

Expected annuity Annuity: 8 - Amount: 160 € - Due date 02/01/2024
Surtax: 8 - Amount: 32 € - Due date 03/07/2024
Last annuity None

Publication None
History

Publication de la délivrance du brevet européen - Legal date 01/11/2023


Entrée en période de grâce du brevet d'invention - Legal date 03/01/2024


Déchéance du brevet d'invention après période de grâce - Legal date 02/01/2024